• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 20
      Episode 62. Unpacking MIDAS Trial in Myeloma with Dr. Meera Mohan | Blood Cancer Talks | Episode 63 - 7 day(s) ago

      In this episode, we dissect the phase 3 MIDAS trial in newly diagnosed transplant-eligible multiple myeloma with Dr. Meera Mohan. https://pubmed.ncbi.nlm.nih.gov/39841461/https://pubmed.ncbi.nlm.nih.gov/40459097/

      Source: share.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        MIDAS under the Microscope: Check out our special episode unpacking MIDAS trial in newly diagnosed #MultipleMyeloma with @MeeraMohanMD! https://t.co/i0ZRHjauci https://t.co/VprJAKIIcn

    • Mashup Score: 20
      Episode 60. Emergency Podcast-AQUILA and STARGLO | Blood Cancer Talks | Episode 61 - 2 month(s) ago

      In this episode, we discuss the recent proceedings at the FDA ODAC meeting on AQUILA trial in smoldering myeloma and STRAGLO in R/R DLBCL, and provide an update to our audience on some of the clinically relevant data presented from those trials, along with insights from the panelists. Here is the…

      Source: share.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        New🚨 EMERGENCY PODCAST 🚨 episode @BloodCancerTalk! Following recent FDA ODAC proceedings, we dissect two pivotal trials & insights from FDA/panelists: 🔸 AQUILA: Daratumumab in high-risk SMM 🔸 STARGLO: Glofitamab in R/R DLBCL https://t.co/LYJ3IDokKZ A short clip on STARGLO: https://t.co/I1raugk4HJ

    • Mashup Score: 18
      Episode 59. Management of Systemic Mastocytosis with Dr. Daniel DeAngelo - 2 month(s) ago

      Podcast Episode · Blood Cancer Talks · 05/08/2025 · 1h 3m

      Source: podcasts.apple.com
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        Tune in to our new episode on management of systemic mastocytosis with Dr. Daniel DeAngelo from @DanaFarber! @AshKishtagari https://t.co/nFc8vt8IZL https://t.co/h6yg9m2qv3

    • Mashup Score: 4
      Introduction to BloodCancerTalks - 3 month(s) ago

      Transistor (https://transistor.fm) https://feeds.transistor.fm/bloodcancertalks This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth. Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston Tweet your suggestions and feedback to @rajshekharu

      Source: feeds.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        At @bloodcancertalks, we are committed to bringing fiercely independent and nuanced coverage of latest advances in hematologic malignancies in a "𝐇𝐨𝐰 𝐈 𝐓𝐫𝐞𝐚𝐭" format from thought leaders in the field! Check out our episodes➡️https://t.co/0QghqgcD9D! https://t.co/d8aj671oPK

    • Mashup Score: 16
      Episode 56. Management of Newly Diagnosed CML with Dr. Hagop Kantarjian - 5 month(s) ago

      Podcast Episode · Blood Cancer Talks · 02/12/2025 · 1h 3m

      Source: podcasts.apple.com
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        Tune in to our new episode on management of CML with @DrHKantarjian! We discuss into the latest asciminib data and nuances of choosing the optimal TKI to use in 1st line! @AshKishtagari https://t.co/5riPdsA5mV https://t.co/G4ct0vUBxc

    • Mashup Score: 6
      Episode 55. ASH 2024 Myeloma Updates with Dr. Rakesh Popat | Blood Cancer Talks | Episode 56 - 6 month(s) ago

      In this episode, we dive into the hottest updates in myeloma and amyloidosis at ASH 2024 annual meeting with Dr. Rakesh Popat. Here are the abstracts we discussed: 1. AQUILA Trial in High-Risk SMMOverview of the AQUILA trial testing single-agent daratumumab for high-risk smoldering multiple…

      Source: share.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        Listen to our new episode on #ASH24 #MultipleMyeloma updates with @DrRakeshPopat! We discuss: AQUILA GMMG-HD7 iMMagine-1 CARTITUDE-4 MRD update ANDROMEDA OS update OPTIMUM-MUKnine update Check out this clip on Dr. Popat's take on anito-cel data! https://t.co/UCYvYo11ew https://t.co/lXT7NETnxs

    • Mashup Score: 2
      Episode 39. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel | Blood Cancer Talks | Episode 39 - 6 month(s) ago

      In this episode, we discuss top abstracts in the myeloid space from the American Society of Hematology 2023 meeting with Dr. Anand Patel. Here are the abstracts that were discussed:1. TRANSFORM-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of…

      Source: share.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        @HangQuach1 @StVHealthAust @ADispenzieri 5. #ASH23 update on leukemia and myeloid malignancies with @Anand_88_Patel! We critically appraised TRANFORM-1, MANIFEST-2, AUGMENT-101, and many more trials! https://t.co/RIdfhUFxbP

    • Mashup Score: 39
      Episode 40. Management of Newly Diagnosed AL Amyloidosis | Blood Cancer Talks | Episode 41 - 6 month(s) ago

      In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. Here are the key articles discussed:1.      Optimal use of tissue biopsy in AL amyloidosis: https://pubmed.ncbi.nlm.nih.gov/28271734/ 2.     Mayo 2004 staging: …

      Source: share.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        Tune in to our new episode on management of AL Amyloidosis with @ADispenzieri! We dive into the nuances of management including tissue biopsy, risk stratification, monitoring patients while on Dara-VCD, and many more critical issues! https://t.co/qH9gsov1p5 Check out this clip: https://t.co/gnMRfBAu1s

    • Mashup Score: 3
      Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach | Blood Cancer Talks | Episode 54 - 6 month(s) ago

      In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts presented at EHA/ASCO 2024. Here are the studies we discussed: 1. DREAMM-7 RCT: Belantamab-Vd vs Daratumumab-Vd in relapsed MM….

      Source: share.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        3. The comeback of belantamab with @HangQuach1 @StVHealthAust! We had a wide-ranging discussion on DREAMM-7 and 8 RCTs, ocular toxicity of belantamab, and how will it fit into the current treatment paradigm! https://t.co/05A4bO4Gle

    • Mashup Score: 1
      Episode 51. Venetoclax in AML with Dr. Andrew Wei | Blood Cancer Talks | Episode 52 - 6 month(s) ago

      In this episode, we discuss the history of venetoclax in AML, along with key clinical trials that have shaped its current use in AML. Here are the trials discussed in this episode: 1. VIALE-A study: https://www.nejm.org/doi/full/10.1056/NEJMoa20129712. 10 day Decitabine plus venetoclax for ND AML…

      Source: share.transistor.fm
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	BloodCancerTalk
        BloodCancerTalk

        1. Venetoclax in AML with Andrew Wei @PeterMacCC ! We discussed the history of venetoclax development and practical tidbits on managing AML with venetoclax-based regimens! https://t.co/WFqqrYi2EP

    Load More

    Blood Cancer Talks

    @BloodCancerTalk

    A podcast exclusively focused on Blood Cancers/Hosts @rajshekharucms @AshKishtagari @Eddie_Cliff /Videos on YouTube: https://t.co/Z7q545bWb6…

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings